Treuman Katz Center for Pediatric Bioethics - 2008 Conference Banking Biological Samples for Pediatric Research Jeffrey R. Botkin, M.D., M.P.H. Professor.

Slides:



Advertisements
Similar presentations
Ann Johnson IRB Administrator, IRB Member. Objectives 1. Identify the components necessary for management and oversight of tissue repositories used for.
Advertisements

TISSUE BANKING Challenging to Say the Least
RESEARCH COMPLIANCE Agenda 1. No Destruction of local research documents after scanning 2. Training for shipping biological samples/specimens 3. Regulatory.
Ethical Considerations in Human Subjects Research Stacey Berg, M.D. Texas Children’s Cancer Center.
Informed Consent Waivers IRB Health Sciences & Behavioral Sciences University of Michigan /26/20091.
Protecting the Privacy of Family Members in Survey and Pedigree Research Jeffrey R. Botkin, MD, MPH University of Utah.
© HRP Associates, Inc. Informed Consent, Parental Permission & Assent Jeffrey M. Cohen, Ph.D., CIP President, HRP Associates, Inc.
Human Specimen Repositories: Requirements of 45 CFR part 46 PRIM&R May 5, 2004 Julie Kaneshiro DHHS Office for Human Research Protections Phone:
Methods repositories use to protect subjects Roger Aamodt, Ph.D. Resources Development Branch, National Cancer Institute.
Storage, Retention, and Use of Residual Dried Blood Spots Storage, Retention, and Use of Residual Dried Blood Spots Harry Hannon, PhD and Brad Therrell,
REPOSITORIES: ETHICAL & REGULATORY ISSUES. PLAN OF ANALYSIS  DEFINITIONS & DISTINCTIONS  CREATION OF REPOSITORIES & IRB APPROVAL  THE INTAKE PROCESS.
COOL THINGS ABOUT THE GENOME Humans have fewer genes than expected Human genes make more proteins than those of other critters Humans have adopted 200.
Treuman Katz Center for Pediatric Bioethics Conference Newborn Screening: The Future Revolution Beth A. Tarini, MD, MS Assistant Professor Child.
Pediatric Ethics Subcommittee of Pediatric Advisory Committee, September 10, 2004 Analysis of Research Protocols Involving Children: Combining Subparts.
Use of Children as Research Subjects What information should be provided for an FP7 ethical review?
IRB 101: Informed Consent Columbia University Medical Center IRB September 22, 2005.
IRB-Investigator/ Research Coordinator Mtg. “Research with Human Tissues at Columbia” March 9, 2004 George Gasparis Columbia University Medical Center.
The Pursuit of Better Medicines through Genetic Research Terri Arledge, DVM US Department Head Drug Development Genetics.
CUMC IRB Investigator Meeting November 9, 2004 Research Use of Stored Data and Tissues.
8 Criteria for IRB Approval of Research 45 CFR (a)
IRB Monthly Investigator Meeting Columbia University Medical Center IRB October 11, 2005.
Human Investigation Committee  Is it research?  If yes, does it involve human subjects?  If yes, can it be exempt?  If no, will a Request for.
Is this Research? Exempt? Expedited?
Avoiding the Pitfalls of an IRB Submission Chris Ayres Chair, Institutional Review Board Social & Behavioral Science & Chair, Department of Kinesiology,
International Research & Research Involving Children K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development.
Regulatory Considerations for Investigational Assays: Planning for Success Elizabeth Mansfield, PhD OIVD/FDA “Next-Generation DNA Sequencing as a Tool.
HRPP Training – Session Two Human Research Protection Program Manager
1 Disclosures © HIPAA Pros 2002 All rights reserved.
Future Use of Stored Samples & Data and the NIH Policy on GWAS and dbGaP NIAID/DAIDS Dione Washington, M.S. -- ProPEP Sudha Srinivasan, Ph.D.-- TRP Tanisha.
Implications for the Use of Tissue in Research P. Pearl O’Rourke, MD Partners HealthCare Boston, MA.
Challenges with conducting NBS pilot studies Jeffrey R. Botkin, M.D., M.P.H. Professor of Pediatrics Chief, Division of Medical Ethics and Humanities Associate.
Ethical and Regulatory Considerations in Research using Residual Specimens Jeffrey R. Botkin, M.D., M.P.H. Professor of Pediatrics and Medical Ethics Associate.
The Secretary’s Advisory Committee on Human Research Protections (SACHRP): Recommendations Regarding the Newborn Screening Reauthorization Act of 2014.
Privacy and Confidentiality. Definitions n Privacy - having control over the extent, timing, and circumstances of sharing oneself (physically, behaviorally,
The Institutional Review Board: A Community College Toolkit Dr. Geri J Anderson.
Special Consideration in Public Health Practice & Research Delia Wolf, MD, JD, MSCI Associate Dean, Regulatory Affairs and Regulatory Compliance Lecturer,
Institutional Review Board Issues for Classroom Research Sharon McWhorter IRB Administrator, The University of Akron (With assistance from Phil Allen,
I have no relevant financial relationships with the manufacturers of any commercial products and/or provider of commercial services discussed in this CME.
HIPAA and Human Subjects Research IRB Member CE May 2014 Slideshow by Sean Horkheimer.
Case Studies: Puzzles in Human Research Kevin L. Nellis, M.S., M.T. (A.S.C.P.) Program Analyst, Program for Research Integrity Development and Education.
APPROVAL CRITERIA AN IRB INFOSHORT MAY CFR CRITERIA FOR IRB APPROVAL OF RESEARCH In order for an IRB to approve a research study, all.
 Epidemiology -- Research – or Not Research? Medical Research Summit March Tom Puglisi, PhD.
Regulatory requirements: children, assent, and consent waivers and waiver of documentation Bob Craig, 2007.
Informed Consent Process Patrick Herbison, MEd, CIP Research Compliance Manager Office of Human Research (OHR)
NCI/NAPBC Model Informed Consent for Future Research Use of Tissue Marianna Bledsoe Resources Development Branch, Cancer Diagnosis Program, National Cancer.
Regulatory Guidance for Genetic Testing. Three Specific Areas Laboratory tests Results of genetic testing – Clinical – Research GenomeWide Association.
Pediatric Research Ethics and the Research Subject Advocate Tomas Jose Silber, MD, MASS RSA and Director, Office of Ethics, CNMC Professor of Pediatrics,
Human Specimen Repositories Requirements of 21 CFR Parts 50 & 56 PRIM & R May 5, 2004 Sally A. Hojvat, Ph.D. Director of Microbiology Devices Office of.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
Legal Responsibilities for Studies Conducted or Supported by HHS Michael A. Carome, M.D. Associate Director for Regulatory Affairs Office for Human Research.
Human Research Protection Program 101 March 20, 2007 Cincinnati, OH.
Storage, Labeling, Controlled Medications Guidance Training CFR § (b)(2)(3)(d)(e) F431.
Upcoming Changes to the Common Rule
Risk Determinations and Research with Children
University of Central Florida Office of Research & Commercialization
The HIPAA Privacy Rule: Implications for Medical Research
Research on human biological materials: Lithuanian perspective
University of Central Florida Office of Research & Commercialization
Changes to Exempt Categories
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Data Access and Stewardship
This takes approximately 5 minutes or less from start to finish
Jeffrey M. Cohen, Ph.D. Associate Dean,
Secondary Research with Identifiable Information and Biospecimens
IRB Educational Session - IRB Regulations on Expedited Review
Which Projects Do – and do Not – Require IRB Review?
Revised Common Rule: Informed Consent Changes
Which Projects Do – and do Not – Require IRB Review?
Special Considerations in Genetic Research
Presentation transcript:

Treuman Katz Center for Pediatric Bioethics Conference Banking Biological Samples for Pediatric Research Jeffrey R. Botkin, M.D., M.P.H. Professor of Pediatrics and Medical Ethics Associate Vice President for Research University of Utah Jeffrey R. Botkin, M.D., M.P.H. Professor of Pediatrics and Medical Ethics Associate Vice President for Research University of Utah

Treuman Katz Center for Pediatric Bioethics Conference 2 Stored Human Tissues “The most serious and intractable issues in health law and ethics today are raised by the collection, storage, and future use of tissue samples. Imagine the vast amount of personal information contained in stored tissue samples …” Professor Lawrence O. Gostin, Georgetown University “The most serious and intractable issues in health law and ethics today are raised by the collection, storage, and future use of tissue samples. Imagine the vast amount of personal information contained in stored tissue samples …” Professor Lawrence O. Gostin, Georgetown University

Treuman Katz Center for Pediatric Bioethics Conference Tissue Banking Increasingly common element of clinical research protocols – –Genotype – phenotype correlations – –Environmental – phenotype correlations – –Pharmacogenomic research – –Toxicogenomic research Increasingly common element of clinical research protocols – –Genotype – phenotype correlations – –Environmental – phenotype correlations – –Pharmacogenomic research – –Toxicogenomic research

Treuman Katz Center for Pediatric Bioethics Conference Tissue Banking Storage of tissue permits easy access to “human subjects” – –Tissues acquired for clinical or research purposes – –Research can be conducted that is remote in time and place Storage of tissue permits easy access to “human subjects” – –Tissues acquired for clinical or research purposes – –Research can be conducted that is remote in time and place

Treuman Katz Center for Pediatric Bioethics Conference Tissue Banking Linkage of results of biological assays with informational databases – –Medical records – –Family history records – –Cancer registries – –Public health records Linkage of results of biological assays with informational databases – –Medical records – –Family history records – –Cancer registries – –Public health records

Treuman Katz Center for Pediatric Bioethics Conference Research with Human Subjects 45CFR46: Human subject means a living individual about whom an investigator (whether professional or student) conducting research obtains (1) Data through intervention or interaction with the individual, or (2) Identifiable private information. 45CFR46: Human subject means a living individual about whom an investigator (whether professional or student) conducting research obtains (1) Data through intervention or interaction with the individual, or (2) Identifiable private information.

Treuman Katz Center for Pediatric Bioethics Conference Research with Human Tissues Use in research is human subjects research if tissue source can be identified – –What constitutes “de-identification?” 45CFR46 the identity of the subject may readily be ascertained by investigator HIPAA: removal of 18 identifiers or expert opinion Use in research is human subjects research if tissue source can be identified – –What constitutes “de-identification?” 45CFR46 the identity of the subject may readily be ascertained by investigator HIPAA: removal of 18 identifiers or expert opinion

Treuman Katz Center for Pediatric Bioethics Conference What are the ethical issues raised by research with human tissues?

Treuman Katz Center for Pediatric Bioethics Conference Ethical and Regulatory Issues Who “owns” tissue samples? Defining the risks to individuals from research with tissue samples Defining the risks to racial or ethnic groups from research with tissues Who “owns” tissue samples? Defining the risks to individuals from research with tissue samples Defining the risks to racial or ethnic groups from research with tissues

Treuman Katz Center for Pediatric Bioethics Conference Ethical and Regulatory Issues What sort of consent should be obtained for research with tissue samples? – –Is consent for unrestricted future use acceptable? – –What is the role of child assent? – –Should consent be obtained when subjects become adults? What sort of consent should be obtained for research with tissue samples? – –Is consent for unrestricted future use acceptable? – –What is the role of child assent? – –Should consent be obtained when subjects become adults?

Treuman Katz Center for Pediatric Bioethics Conference Case Discussion Retention and research use of residual newborn screening blood spots

Treuman Katz Center for Pediatric Bioethics Conference Residual Newborn Screening Specimens Virtually all newborns are screened for multiple conditions using dried blood spots State-based public health programs Residual dried blood spots are available for almost all infants Virtually all newborns are screened for multiple conditions using dried blood spots State-based public health programs Residual dried blood spots are available for almost all infants

Treuman Katz Center for Pediatric Bioethics Conference Reasons for Specimen Storage Confirmation of test results Quality assessment of current test modalities Forensic uses – – Post-mortem disease identification – – Identification of remains Research – – Related to newborn screening – – Unrelated to newborn screening Confirmation of test results Quality assessment of current test modalities Forensic uses – – Post-mortem disease identification – – Identification of remains Research – – Related to newborn screening – – Unrelated to newborn screening

Treuman Katz Center for Pediatric Bioethics Conference Reasons for Discarding Specimens Uncertainty over stability of sample – – DNA appears stable Storage costs and space No clearly defined justification for storage Lack of informed consent for retention Potential legal liabilities Uncertainty over stability of sample – – DNA appears stable Storage costs and space No clearly defined justification for storage Lack of informed consent for retention Potential legal liabilities

Treuman Katz Center for Pediatric Bioethics Conference NBS Retention < 6 months 24 programs 1 year 6 programs years 7 programs years 6 programs indefinitely 8 programs 37 states have policies governing use of residual samples 23 programs have written usage policy < 6 months 24 programs 1 year 6 programs years 7 programs years 6 programs indefinitely 8 programs 37 states have policies governing use of residual samples 23 programs have written usage policy Source: Therrell et al. Pediatrics 2006;117:S212

Treuman Katz Center for Pediatric Bioethics Conference Research Options “Anonymized” specimens Pros – – Valuable for epidemiologic research – – Research does not involve “human subjects” under US regulations – – Minimal IRB review IRB defines exempt research IRB may review de-identification process – – No consent usually necessary for anonymous use (consent may be appropriate for collection and storage) “Anonymized” specimens Pros – – Valuable for epidemiologic research – – Research does not involve “human subjects” under US regulations – – Minimal IRB review IRB defines exempt research IRB may review de-identification process – – No consent usually necessary for anonymous use (consent may be appropriate for collection and storage)

Treuman Katz Center for Pediatric Bioethics Conference Research Options “Anonymized” specimens Cons – – Unable to link with health outcome of child Cannot detect false positives and false negatives – – Unable to contact family with beneficial health information “Anonymized” specimens Cons – – Unable to link with health outcome of child Cannot detect false positives and false negatives – – Unable to contact family with beneficial health information

Treuman Katz Center for Pediatric Bioethics Conference Research Options Linked samples (identifiable) Pros – – Health tracking possible – – Return of health information possible Cons – – IRB review and oversight necessary – – Informed permission may be necessary Undermines value of having a specimen already – – Return of information may pose risk to child and/or family Linked samples (identifiable) Pros – – Health tracking possible – – Return of health information possible Cons – – IRB review and oversight necessary – – Informed permission may be necessary Undermines value of having a specimen already – – Return of information may pose risk to child and/or family

Treuman Katz Center for Pediatric Bioethics Conference Informed Permission in NBS Permission usually not sought for NBS – – Only 2 states and DC have permission process for NBS – – No infrastructure for obtaining permission Acquire permission for retention of sample for research purposes? Acquire permission for research use? – – Research specific to newborn screening conditions? – – Broad authorization for other research uses? Permission usually not sought for NBS – – Only 2 states and DC have permission process for NBS – – No infrastructure for obtaining permission Acquire permission for retention of sample for research purposes? Acquire permission for research use? – – Research specific to newborn screening conditions? – – Broad authorization for other research uses?

Treuman Katz Center for Pediatric Bioethics Conference Waiver of Consent Permitted under 45 CFR d if all criteria are met: 1) research involves no more than minimal risk 2) waiver would not adversely affect rights and welfare of the subject 3) research could not be practicably carried out without waiver 4) when appropriate, subjects can be provided with pertinent information after participation

Treuman Katz Center for Pediatric Bioethics Conference Policy Questions Should state health departments be able to retain NBS specimens without parental permission? Is biomedical research permissible with retained specimens without parental permission? – –Anonymous specimens only? – –Identifiable specimens? Should state health departments be able to retain NBS specimens without parental permission? Is biomedical research permissible with retained specimens without parental permission? – –Anonymous specimens only? – –Identifiable specimens?

Treuman Katz Center for Pediatric Bioethics Conference